Talk about team spirit! Quantify’s Oskar Frisell, Mathias Lilja, Rosa Lauppe, Fredrik Borgström, Lena Jacobs and Kirk Geale teamed up to develop a cost-effectiveness model for the treatment of uterine fibroids in women of reproductive age in England that was presented at the ESG 2021 conference. To assess the clinical efficacy of treatment a generalised symptom-based algorithm that links menstrual blood loss to EQ5D for use in CE models was developed, which was presented at Virtual ISPOR 2021.
Check out their work here: https://lnkd.in/gcTx9tYr and here: https://lnkd.in/gWu2jnzZ